000 01878 a2200541 4500
005 20250514065208.0
264 0 _c20030605
008 200306s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI17500
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPetkov, Ventzislav
245 0 0 _aVasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cMay 2003
300 _a1339-46 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCell Division
_xphysiology
650 0 4 _aCells, Cultured
650 0 4 _aExercise
650 0 4 _aFemale
650 0 4 _aHemodynamics
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xblood
650 0 4 _aImmunohistochemistry
650 0 4 _aLung
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscle, Smooth, Vascular
_xmetabolism
650 0 4 _aMyocytes, Smooth Muscle
_xpathology
650 0 4 _aRadioligand Assay
650 0 4 _aReceptors, Vasoactive Intestinal Peptide
_xgenetics
650 0 4 _aReceptors, Vasoactive Intestinal Peptide, Type II
650 0 4 _aReceptors, Vasoactive Intestinal Polypeptide, Type I
650 0 4 _aVasoactive Intestinal Peptide
_xblood
700 1 _aMosgoeller, Wilhelm
700 1 _aZiesche, Rolf
700 1 _aRaderer, Markus
700 1 _aStiebellehner, Leopold
700 1 _aVonbank, Karin
700 1 _aFunk, Georg-Christian
700 1 _aHamilton, Gerhard
700 1 _aNovotny, Clemens
700 1 _aBurian, Bernhard
700 1 _aBlock, Lutz-Henning
773 0 _tThe Journal of clinical investigation
_gvol. 111
_gno. 9
_gp. 1339-46
856 4 0 _uhttps://doi.org/10.1172/JCI17500
_zAvailable from publisher's website
999 _c12517091
_d12517091